EN
HI

Gennex Laboratories Share price

GENNEX

HealthcareSmall

13.9

0.11 (0.80%)
Last updated on 30 May, 2025 | 15:44 IST
BUYSELL
Today's High

14.00

Today's Low

13.00

52 Week Low

11.15

52 Week High

29.00

The current prices are delayed, login to your account for live prices

Gennex Laboratories Chart

Gennex Laboratories Share Key Metrics

Volume
5.61 L
Market Cap
316.15 CR
LTQ@LTP
50@13.90
ATP
13.76
Var Margin
26.94 %
Circuit Range
11.04-16.54
Delivery %
0 %
Value
77.22 L
ASM/GSM
No
Market Lot
1

Gennex Laboratories Futures & Options

Data Not Found

Gennex Laboratories Corporate Actions

DateAgenda
2025-05-30Audited Results
2025-02-14Quarterly Results
DateEvent TypeAgenda
2025-05-30Board MeetingAudited Results
2025-02-14Board MeetingQuarterly Results

Gennex Laboratories News

No Data Found

About Gennex Laboratories

NSE : 0  
BSE : 531739  
ISIN : INE509C01026  

PRUDENTIAL PHARMACEUTICALS LIMITED was originally incorporated under the name of Pharmasia Drugs and Chemicals Private Limited on 25th June 1985 in the state of Karnataka. The Company was subsequently shifted to Andhra Pradesh with effect from 29th March 1990. The Company has been promoted by Pharmasia Limited a Company registered under the Companies Act 1956 and having its registered office at 49 BHEL Enclave Akbar Road Secunderabad - 500 003. The Company had acquired a sick bulk drug manufacturing unit of SPS Chemicals Private Limited a sick unit assisted by the Andhra Pradesh State Financial Corporation Limited located at 133 Bollaram Medak Dist. in an auction in January 1993 by paying a lumpsum consideration of Rs.13.25 lacs and undertaking to pay off the term loan overdues amounting to Rs.24 lacs to APSFC which has since been paid off.The Company became a Deemed Public Limited Company with effect from 6th February 1993 as per the provisions of section 43A(1) of the Companies Act 1956. The Company was converted to a Public Limited Company by a resolution passed by its members at the Extraordinary General Body Meeting held on 3rd November 1994. A fresh certificate of incorporation consequent upon the conversion of the Company was issued by the Registrar of Companies Andhra Pradesh on 15th February 1995. The Company''s name was subsequently changed to Prudential Pharmaceuticals Limited and a fresh certificate of incorporation consequent upon change of name of the Company was issued by the Registrar of Companies Andhra Pradesh on 22nd February 1995.Mr.Vinod Baid & his associates acquired the entire holding of Pharmasia Limited amounting to 140018 shares at their face value (the consideration for which has been paid in cash) in November 1994 with a view to implement the project to set up facilities for manufacturing bulk drugs.The controlling interest held by the erstwhile promoter group was acquired by Mr.Vinod Baid & Associates by transfer of shares by following the procedure set out in the Companies Act 1956 and the rules framed there under i.e. by executing transfer deeds in prescribed form in favour of the transferees.At the time of take-over the Company had certain plant and machinery which has been detailed elsewhere in the prospectus and had also placed orders for certain other plant and machinery. After the takeover the company under the new management had taken up the implementation of the project in right earnest. The products were identified additional equipment required (other than those already available and those ordered) were acquired and the manpower required for manning the project were hired. The trial production was completed in September 1995 and the Commercial Production has already commenced.The Details of the position of the Company as at 31st March 1994 the cut-off date considered by Mr. Vinod Baid & Associates for the purpose of acquisition of controlling interest in the Company has been given as under:

Gennex Laboratories Management

NamePosition
Mr. Arihant Baid Managing Director
Dr. S Dharma Rao Non Executive Director
Dr. A R R Pantulu Non Executive Director
Mr. Mohammed Khaleequr Rahman Non Executive Director
Mr. A S Nageswar Rao Independent Director
Read More

Gennex Laboratories FAQs

The Buying Price of Gennex Laboratories share is 13.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Gennex Laboratories share log in to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of Gennex Laboratories shares is 16.98. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Gennex Laboratories shares is 1.76. Useful to assess the stock's value relative to its book value.

To assess Gennex Laboratories’s valuation compare Sector P/E, P/B which are 37.05 & 4.02 with sector averages, along with growth rates and financial metrics.

The Market Cap of Gennex Laboratories is 316.15 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Gennex Laboratories share price is 29.00 & 11.15. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.